Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 764 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Regulatory Filings
2026-05-04 English
DISCLOSEABLE TRANSACTION - DEEMED ACQUISITION OF EQUITY INTEREST IN SICHUAN RUIJIAN MEDICAL BY ITS PROPOSED SHARE REPURCHASE
Regulatory Filings
2026-04-30 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued shares and extensive on-market share repurchases by PW Medtech Group Limited. This is a regulatory disclosure of the company’s own share transactions (buybacks and treasury shares). According to FinancialReports categories, this corresponds to “Transaction in Own Shares” (Code: POS).
2026-04-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Hong Kong Stock Exchange "Next Day Disclosure Return" (Form FF305) detailing changes in issued shares and treasury shares, specifically a series of share repurchases for cancellation and a repurchase report (Section II). This is a direct disclosure of the company’s own share transactions (buybacks). Under our taxonomy, such share repurchase/own‐share transaction disclosures fall under Transaction in Own Shares (Code: POS).
2026-04-24 English
Notification Letter and Request Form to Non-Registered Shareholders
Report Publication Announcement Classification · 1% confidence The document is a notification letter to non-registered shareholders informing them of the publication of the Company’s Annual Report 2025 and a Circular (covering share repurchase/issuance mandates, director re-election and the 2026 AGM notice) on the Company’s and Stock Exchange’s websites, and includes a request form for printed copies. This is not the report or circular itself but an announcement that they are available online. According to the “menu vs meal” rule, it is a Report Publication Announcement (RPA).
2026-04-24 English
Notification Letter and Reply Form to Registered Shareholders
Report Publication Announcement Classification · 1% confidence The document is a notification letter to shareholders informing them of the publication of the Annual Report 2025, a circular on mandates and AGM notice, and the form of proxy, and directs them to the company website or HKEX for access. It does not contain the substantive annual report or circular itself but simply announces their availability. This matches the definition of a Report Publication Announcement (RPA).
2026-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.